Disc Medicine, Inc. IRON
76.11 USD -1.87 (-2.40%)
Regular-session close
76.11 0.00 0.00%
After hours · Nov 19, 4:26 PM ET
75.98 Day range 78.90
40.00 52-week range 99.50
- YTD
- -4.16%
- 1 year
- -16.12%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 127.69 +67.8% upside
Now 76.11
- Target (low)
- 104.00
- Target (mean)
- 127.69
- Target (high)
- 170.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy1
- Buy12
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
- 3 months ago 13
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.52 | -1.71 – -1.36 | -1.62 | +6.1% | 0 | 0.0% | 9 |
| Next quarter | -1.59 | -1.81 – -1.45 | -1.65 | +3.8% | 0 | 0.0% | 7 |
| Current year | -6.11 | -6.44 – -5.11 | -6.01 | -1.7% | 0 | 0.0% | 9 |
| Next year | -6.18 | -6.93 – -5.43 | -6.11 | -1.1% | 43.54M | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 9, 2026 | Guggenheim | Initiated | — | Buy |
| Nov 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 20, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 20, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 20, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 20, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 19, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Oct 19, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Sep 16, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 10, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 2, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 16, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 10, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| May 14, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 2, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Feb 17, 2026 | Stifel | Maintained | Buy | Buy |
| Feb 17, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Feb 17, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 17, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 17, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 16, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 10, 2025 | Truist Securities | Maintained | Buy | Buy |
| Oct 30, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 17, 2025 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Oct 17, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 17, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Aug 18, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 21, 2025 | Truist Securities | Initiated | — | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
